| I-36 Anna Mishina Simulation of Rituximab and Natalizumab biomarker efficacy using simplified QSP model of B- and T- lymphocyte dynamics in Multiple Sclerosis Wednesday 09:45-11:15 |
| I-36 Anna Mishina Simulation of Rituximab and Natalizumab biomarker efficacy using simplified QSP model of B- and T- lymphocyte dynamics in Multiple Sclerosis Wednesday 09:45-11:15 |